- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04478578
남아시아 및 동남아시아 농촌 지역의 열병 발생률, 원인 및 결과 (SEACTN-WP-A)
남아시아 및 동남아시아 지역사회 기반 시험 네트워크(SEACTN)의 일환으로 남아시아 및 동남아시아에서 농촌 열병(RFI)의 발병률, 원인 및 결과 결정. 작업 패키지 A(WP-A).
The study will collect information to understand the causes and outcomes of febrile illness in rural areas in countries across South and Southeast Asia (including Cambodia, Laos, Myanmar and Bangladesh). The findings will be used to identify new tests and treatments that can improve the management of febrile patients in the future.
This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z
연구 개요
상태
정황
상세 설명
This study aims to better understand and quantify the burden of febrile illness, the aetiological causes and the manner in which it affects the people living in rural areas in South and Southeast Asia, all on a scale which has not been attempted before. The SEACTN RFI project will collect information to help better understand and predict these outcomes based on a multitude of factors, which will form the basis for interventions within the network in the future. Determining the incidence, causes and outcomes of febrile illness in these settings will be done through two work packages. The first of these, Work Package A (WP-A), the subject of this study, will be carried out at the community level, primarily by engaging village health worker (VHWs) and low-level Health Centres (HCs) which serve the communities to recruit patients presenting with a febrile illness. These patients will be assessed for presenting symptoms and followed up for clinical outcomes. Collection of specimen for diagnostic investigations in these settings is challenging. Currently, mRDTs are conducted by VHWs and HCs in these networks, therefore by using the same process, but also applying blood to filter paper and allowing it to dry (DBS), investigators will test for certain other pathogens, which will increase the aetiological yield.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Vientiane Prefecture
-
Vientiane, Vientiane Prefecture, 라오스, 01000
- Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)
-
-
-
-
-
Dhaka, 방글라데시, 1212
- Building Resources Across Communities (BRAC)
-
-
-
-
-
Yangon, 버마, 11201
- Medical Action Myanmar (MAM)
-
-
-
-
-
Battambang, 캄보디아
- Action for Health Development (AHEAD)
-
-
-
-
-
Chiang Rai, 태국, 57000
- Chiangrai Clinical Research Unit (CCRU)
-
-
Bangkok
-
Ratchathewi, Bangkok, 태국, 10400
- Mahidol VivaResearch Unit, Faculty of Tropical Medicine, Mahidol University (MVRU)
-
-
Changwat Tak
-
Mae Sot, Changwat Tak, 태국, 63110
- Shoklo Malaria Research Unit (SMRU)
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Patients with an acute febrile illness of all ages presenting to village health workers (VHWs) or peripheral health facilities.
설명
Inclusion Criteria:
- Documented fever (≥ 37.5°C axillary), hypothermia (< 35.5°C) and/or history of fever in the last 24 hours.
- Willingness and ability to comply with study protocol for the study duration.
- Written informed consent given to participate in the trial.
Exclusion Criteria:
- Currently enrolled in the study
- Accident or trauma is the cause for presentation
- Presentation ≤ 3 days after routine immunisations
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: CASE_ONLY
- 시간 관점: PROSPECTIVE
코호트 및 개입
그룹/코호트 |
|---|
|
Patients with febrile illness
Participants from approximately 650 villages, with a target number of 100,000 episodes of febrile illness, will be enrolled into this study. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Local incidence of febrile illness
기간: From Months 0 to 24
|
The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the village level. |
From Months 0 to 24
|
|
Overall incidence of febrile illness
기간: From Months 0 to 24
|
The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the regional level. These estimates will later be triangulated with and extrapolated from using health seeking behavior surveys for an estimate of the total incidence of febrile illness. |
From Months 0 to 24
|
|
Mortality
기간: Within approximately 1 month of first presentation to the village health worker or health facility
|
Case fatality rates in febrile illness |
Within approximately 1 month of first presentation to the village health worker or health facility
|
|
Morbidity
기간: Over 1 month after first presentation
|
Duration of illness in patients presenting with a fever to the village health worker or health facility. |
Over 1 month after first presentation
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Prevalence of pathogens in febrile patients
기간: Samples collected over approximately 24 months
|
Pathogens will be detected in patients presenting over a 24 month period using point of care tests and diagnostic assays on acute and convalescent dried blood spots. |
Samples collected over approximately 24 months
|
|
The correlation between host biomarker concentrations, aetiological diagnoses and clinical outcomes.
기간: Samples collected over approximately 24 months
|
The area under the curve, sensitivity and specificity of host biomarkers to identify bacterial infections and to predict severe outcomes. |
Samples collected over approximately 24 months
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: Yoel Lubell, Prof, Mahidol Oxford Tropical Medicine Research Unit
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.
IPD 공유 기간
After completion of trial activities and reporting
IPD 공유 액세스 기준
MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .